Brian DeSchuytner
Director of Finance/CFO at MERSANA THERAPEUTICS, INC.
Net worth: 155 356 $ as of 2024-04-29
Profile
Brian DeSchuytner is currently the Senior VP, Chief Operating & Financial Officer at Mersana Therapeutics, Inc. He previously worked as the Vice President-ZEJULA Commercial at Tesaro, Inc. from 2017 to 2019, and as the VP-Global Marketing & Head-Global Brand at Millennium Pharmaceuticals, Inc. from 2009 to 2017.
Mr. DeSchuytner completed his undergraduate degree at Dartmouth College and holds an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-14 | 54,511 ( 0.04% ) | 155 356 $ | 2024-04-29 |
Brian DeSchuytner active positions
Companies | Position | Start |
---|---|---|
MERSANA THERAPEUTICS, INC. | Director of Finance/CFO | 2019-07-09 |
Former positions of Brian DeSchuytner
Companies | Position | End |
---|---|---|
TESARO INC | Corporate Officer/Principal | 2019-05-31 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2016-12-31 |
Training of Brian DeSchuytner
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Dartmouth College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MERSANA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Brian DeSchuytner